East Windsor, NJ – The Sami-Sabinsa Group has long been involved with sustainable agricultural practices. As stewards of traditional Indian herbs, the company wants to ensure that the highly valued but neglected Pterocarpus Marsupium (vijaysar) tree series continues to survive. Pterocarpus marsupium extracts from the Indian Kino tree have been...
East Windsor, NJ - In a recent published study in the Journal of Dietary Supplements, researchers found that Pterocarpus marsupium extracts manufactured by Sami Labs (the manufacturing arm of Sabinsa Corporation) lowered blood glucose and HbA1c levels, increasing the levels of the hormone insulin in diabetic rats. Conducted at the Department of...
East Windsor, NJ — Sabinsa has been granted a U.S. patent on the company’s shelf stable probiotic LactoSpore in combination with cranberry seed fibers. Patent No. US9717766 discloses a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 in a synbiotic composition containing natural plant fibers from Vaccinium...
SPRING, Texas — Trust Transparency Consulting announced that Sabinsa Corp. has become a founding board member of the Global Curcumin Association (GCA), established through Trust Transparency’s incubator program of single ingredient trade associations. Sabinsa is a global ingredient supplier with a broad scientific and intellectual property platform to support its...
East Windsor, NJ – Sabinsa Cosmetics, a division of the Sami Labs – Sabinsa Group, has been granted two new patents on cosmetic compositions involving sunscreen lotions and hair growth formulations – one in the U.S. and the other in the E.U. United States patent US 9498423 describes a synergistic...
East Windsor, N.J. — Shaheen Majeed has been promoted to president of Sabinsa Worldwide, with responsibility for manufacturing, marketing, strategies and other operational matters, the company announced on Tuesday. Shaheen’s first job was in the Sabinsa warehouse when he was 17, and over the past 23 years he has held...
East Windsor, NJ – A study that further consolidates the role Sabinsa’s C3 Complex®/BioPerine® combination plays in the context of diabetes was just published in Complementary Therapies in Medicine Panahi et al 33(2017)1-5. The study http://dx.doi.org/10.1016/j.ctim.2017.05.006 demonstrated the protective role the C3 Complex®/BioPerine® combo play in maintaining HDL functionality, reducing...
East Windsor, NJ — A recent study published in Complementary Therapies in Medicine Panahi, shows the role a combination of Sabinsa’s Curcumin C3 Complex/BioPerine plays in the context of diabetes. In the study, the combination works in a protective capacity in regards to maintenance of HDL functionality and in the...
East Windsor, NJ — Sabinsa Corporation’s shelf-stable probiotic LactoSpore was recently granted a U.S. patent approving the use of Lactospore (Bacillus coagulans MTCC 5856) as a therapy for the management of Irritable Bowel Syndrome (IBS). A Product License was issued to Sabinsa for its Lactospore product by Health Canada, the federal...
Langen, Germany – Sabinsa Corp., a manufacturer, supplier and marketer of dietary supplements and more, is taking action in civil court against German company, Biotikon Produkte der Komplementärmedizin, for false advertising and for using the company’s trademark. In a news release, Sabinsa notes requesting Biotikon, to cease and desist the...
